BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide (15 amino acids) derived from research on naturally occurring gastric peptides
2% GHK-Cu represents a middle ground favored by users who have tolerated 1% well and want a somewhat stronger signal for firmness and texture
pubmed-bpc157-systematic-review-2025 WADA Prohibited List: S0 Non-Approved Substances S0 Non-Approved Substances prohibits at all times any pharmacological substance with no current governmental approval for human therapeutic use, explicitly naming BPC-157 among examples
More recent preclinical work has examined GHK-Cu in rodent models of pulmonary fibrosis, silicosis and airway remodelling, with oxidative stress and inflammatory signalling as the reported endpoints
Based on clinical trial evidence, the standard cagrilintide starting dose is 0.6 mg weekly , administered subcutaneously
Evidence-Strength Summary Common Misinterpretations Glycerol release is not identical to long-term adipose reduction